Tag: Leah Christl

April 8, 2016 Off

Biosimilars: More Treatment Options Are on the Way

By Dino Mustafić

As the medical market grows, the US Food and Drug Administration FDA has published a neat piece about biosimilars. Recently, FDA has approved a second biosimilar product—Inflectra (Infliximab-dyyb), a biosimilar to Remicade (infliximab)—and expects to approve other biosimilars in the future.